Advertisement
Onglyza (saxagliptin) may interact with other medications that might cause low blood sugar. Onglyza is classified as a Pregnancy Category B medication by the U.S. Food and Drug Administration. This means it did not harm a fetus when tested in pregnant animals but has not been tested in pregnant humans.
Continue Learning about Antidiabetic
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.